z-logo
Premium
音乐疗法对癌症患者的效果:系统评估与荟萃分析
Author(s) -
Li Yanfei,
Xing Xin,
Shi Xiue,
Yan Peijing,
Chen Yajing,
Li Meixuan,
Zhang Weiyi,
Li Xiuxia,
Yang Kehu
Publication year - 2020
Publication title -
journal of advanced nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 155
eISSN - 1365-2648
pISSN - 0309-2402
DOI - 10.1111/jan.14313
Subject(s) - music therapy , anxiety , medicine , randomized controlled trial , meta analysis , quality of life (healthcare) , depression (economics) , physical therapy , systematic review , intervention (counseling) , medline , clinical trial , psychiatry , nursing , political science , law , economics , macroeconomics
Aims To assess the effectiveness of music therapy on the quality of life, anxiety, depression and pain of patients with cancer. Design Systematic review. Data Sources Five electronic databases were searched in September 2018 for randomized controlled trials evaluating music therapy for patients with cancer. Review Methods The quality of the studies was assessed using the risk of bias tool recommended by the Cochrane Handbook Version 5.1.0 and the Revman version 5.3 software was used to perform the meta‐analysis. The outcomes were overall quality of life, anxiety, depression and pain. Results A total of 19 trials evaluating 1,548 patients were included in this study, of which 765 were in the control group and 783 in the experimental group. Compared with standard care, music therapy can significantly increase the score of the overall quality of life in patients with cancer. In addition, music therapy was found to be more effective for decreasing the score of anxiety, depression and pain. Conclusion Music therapy can improve the overall quality of life of patients with cancer, with an observed optimal intervention duration of 1–2 months. Meanwhile, anxiety, depression and pain are improved as well. Nevertheless, high‐quality trials are still needed to further determine the effects of music intervention in supportive cancer care.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here